Comprehensive Study on the Global SPECT Radiopharmaceuticals Market
Global SPECT Radiopharmaceuticals Market The global SPECT Radiopharmaceuticals market was valued at US$ 5169 million in 2024 and is anticipated to reach US$ 15040 million by 2031, witnessing a CAGR of 16.7% during the forecast period 2025-2031. Single-photon emission computed tomography (SPECT) radiopharmaceuticals remain a cornerstone of nuclear medicine diagnostics worldwide thanks to broad clinical utility, lower cost vs. PET in many settings, and extensive installed SPECT/SPECT-CT base. Key isotope chemistry centers on technetium-99m (Tc-99m)-labeled kits, iodine-123 (I-123), and other gamma-emitters used for cardiology (myocardial perfusion imaging), bone scans, infection/inflammation imaging, neuroimaging (dopaminergic tracers), and organ function studies (renal, thyroid). The market is shaped by isotope supply (Mo-99/Tc-99m generator networks), regulatory controls, reimbursement policies, and ongoing clinical adoption in emerging markets as healthcare access ex...